Attention Deficit Hyperactivity Disorder Clinical Trials Pipeline Analysis: 20+ Companies are Working to Improve the Treatment Space | DelveInsight
17 juil. 2023 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, July 17, 2023 (GLOBE NEWSWIRE) -- Attention Deficit Hyperactivity Disorder Clinical Trials Pipeline Analysis: 20+ Companies are Working to Improve the Treatment Space | DelveInsight ...
Advinus Therapeutics and P2D Bioscience Enter Into a Research and Development Collaboration for Attention Deficit Hyperactivity Disorder (ADHD)
24 juil. 2012 08h35 HE
|
P2D Bioscience
CINCINNATI, OH and BANGALORE, INDIA--(Marketwire - Jul 24, 2012) - Advinus Therapeutics Ltd., a drug discovery and development company, and P2D Bioscience, a CNS-focused specialty...
P2D Bioscience Announces Enhanced Patent Position for Lead ADHD Drug
26 avr. 2011 10h15 HE
|
P2D Bioscience
CINCINNATI, OH and MUMBAI, INDIA--(Marketwire - Apr 26, 2011) - www.p2dinc.com ...
P2D Bioscience Lead ADHD Drug Demonstrates Efficacy in Preclinical Testing
12 avr. 2011 08h00 HE
|
P2D Bioscience
CINCINNATI, OH and MUMBAI, INDIA--(Marketwire - Apr 12, 2011) - P2D Bioscience (P2D, Inc.), a pharmaceutical development company, today announced that its lead Attention Deficit/Hyperactivity Disorder...